Clinical trial/clinical trial/Eledon Pharmaceuticals

Tegoprubart (immune protection)

Better immune protection could make islet transplantation safer and more durable, which directly affects how usable every cell-replacement cure becomes.

How it works

An antibody that calms a specific immune signal (CD40 ligand), studied as a gentler way to protect transplanted islet cells than today's standard immune-suppressing regimens.

Approach

Anti-CD40L immune modulation for transplants

Immunosuppression

Aims to replace standard immunosuppression

Live trial status

No registered clinical trial is tracked for this program yet (it may be preclinical or early). See the official program links for the latest.

These are research programs pursuing a functional cure or disease modification for type 1 diabetes. None is a confirmed, broadly available cure. Trial status is informational, not medical advice, and not a recruiting offer. Verify eligibility and details with the official trial record and a clinician.

Family-tested T1D gear

Some links below are affiliate links. If you buy through them, Type1Cure may earn a small commission at no extra cost to you. Affiliate relationships never affect our research coverage, evidence labels, rankings, or safety alerts.

Daily gearCGM adhesive patchesKeep sensors on through sports, showers, and sweat. A daily-life staple for T1D families.Daily gearInsulated diabetes travel caseOrganize insulin, supplies, and a backup kit for school, travel, and emergencies.LowsFast-acting glucose tabletsA reliable low-treatment to keep in every bag, locker, and nightstand.LearningBooks on living with type 1Guides for newly-diagnosed families, teens, and caregivers learning the ropes.